Table of Content

1. Product Overview
2. Research Methodology
3. Executive Summary
4. Impact of COVID-19 on Global Viral & Non-Viral Vector Manufacturing Market
5. Voice of Customer
6. Global Viral & Non-Viral Vector Manufacturing Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Vector Type (Viral Vector v/s Non-Viral Vector)
6.2.1.1. By Viral Vector (Adenoviral Vector, Retroviral Vector, Lentiviral Vector, Vaccinia Viral Vector, Others)
6.2.1.2. By Non-Viral Vector (Plasmid DNA, Lipid-Based Non-Viral Vector, Polymer-Based Non-Viral Vector, Others)
6.2.2. By Indication (Cancer, Genetic Disease, Infectious Disease, Cardiovascular Diseases, Others)
6.2.3. By Application (Gene Therapy, Vaccinology, Cell Therapy, Others)
6.2.4. By Region
6.2.5. By Company (2021)
6.3. Market Map
7. North America Viral & Non-Viral Vector Manufacturing Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Vector Type (Viral Vector v/s Non-Viral Vector)
7.2.1.1. By Viral Vector (Adenoviral Vector, Retroviral Vector, Lentiviral Vector, Vaccinia Viral Vector, Others)
7.2.1.2. By Non-Viral Vector (Plasmid DNA, Lipid-Based Non-Viral Vector, Polymer-Based Non-Viral Vector, Others)
7.2.2. By Indication (Cancer, Genetic Disease, Infectious Disease, Cardiovascular Diseases, Others)
7.2.3. By Application (Gene Therapy, Vaccinology, Cell Therapy, Others)
7.2.4. By Country
7.3. North America: Country Analysis
7.3.1. United States Viral & Non-Viral Vector Manufacturing Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Vector Type
7.3.1.2.2. By Indication
7.3.1.2.3. By Application
7.3.2. Mexico Viral & Non-Viral Vector Manufacturing Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Vector Type
7.3.2.2.2. By Indication
7.3.2.2.3. By Application
7.3.3. Canada Viral & Non-Viral Vector Manufacturing Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Vector Type
7.3.3.2.2. By Indication
7.3.3.2.3. By Application
8. Europe Viral & Non-Viral Vector Manufacturing Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Vector Type (Viral Vector v/s Non-Viral Vector)
8.2.1.1. By Viral Vector (Adenoviral Vector, Retroviral Vector, Lentiviral Vector, Vaccinia Viral Vector, Others)
8.2.1.2. By Non-Viral Vector (Plasmid DNA, Lipid-Based Non-Viral Vector, Polymer-Based Non-Viral Vector, Others)
8.2.2. By Indication (Cancer, Genetic Disease, Infectious Disease, Cardiovascular Diseases, Others)
8.2.3. By Application (Gene Therapy, Vaccinology, Cell Therapy, Others)
8.2.4. By Country
8.3. Europe: Country Analysis
8.3.1. France Viral & Non-Viral Vector Manufacturing Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Vector Type
8.3.1.2.2. By Indication
8.3.1.2.3. By Application
8.3.2. Germany Viral & Non-Viral Vector Manufacturing Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Vector Type
8.3.2.2.2. By Indication
8.3.2.2.3. By Application
8.3.3. United Kingdom Viral & Non-Viral Vector Manufacturing Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Vector Type
8.3.3.2.2. By Indication
8.3.3.2.3. By Application
8.3.4. Italy Viral & Non-Viral Vector Manufacturing Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Vector Type
8.3.4.2.2. By Indication
8.3.4.2.3. By Application
8.3.5. Spain Viral & Non-Viral Vector Manufacturing Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Vector Type
8.3.5.2.2. By Indication
8.3.5.2.3. By Application
9. Asia-Pacific Viral & Non-Viral Vector Manufacturing Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Vector Type (Viral Vector v/s Non-Viral Vector)
9.2.1.1. By Viral Vector (Adenoviral Vector, Retroviral Vector, Lentiviral Vector, Vaccinia Viral Vector, Others)
9.2.1.2. By Non-Viral Vector (Plasmid DNA, Lipid-Based Non-Viral Vector, Polymer-Based Non-Viral Vector, Others)
9.2.2. By Indication (Cancer, Genetic Disease, Infectious Disease, Cardiovascular Diseases, Others)
9.2.3. By Application (Gene Therapy, Vaccinology, Cell Therapy, Others)
9.2.4. By Country
9.3. Asia-Pacific: Country Analysis
9.3.1. China Viral & Non-Viral Vector Manufacturing Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Vector Type
9.3.1.2.2. By Indication
9.3.1.2.3. By Application
9.3.2. India Viral & Non-Viral Vector Manufacturing Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Vector Type
9.3.2.2.2. By Indication
9.3.2.2.3. By Application
9.3.3. Japan Viral & Non-Viral Vector Manufacturing Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Vector Type
9.3.3.2.2. By Indication
9.3.3.2.3. By Application
9.3.4. South Korea Viral & Non-Viral Vector Manufacturing Market Outlook
9.3.4.1. Market Size & Forecast
9.3.4.1.1. By Value
9.3.4.2. Market Share & Forecast
9.3.4.2.1. By Vector Type
9.3.4.2.2. By Indication
9.3.4.2.3. By Application
9.3.5. Australia Viral & Non-Viral Vector Manufacturing Market Outlook
9.3.5.1. Market Size & Forecast
9.3.5.1.1. By Value
9.3.5.2. Market Share & Forecast
9.3.5.2.1. By Vector Type
9.3.5.2.2. By Indication
9.3.5.2.3. By Application
10. South America Viral & Non-Viral Vector Manufacturing Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Vector Type (Viral Vector v/s Non-Viral Vector)
10.2.1.1. By Viral Vector (Adenoviral Vector, Retroviral Vector, Lentiviral Vector, Vaccinia Viral Vector, Others)
10.2.1.2. By Non-Viral Vector (Plasmid DNA, Lipid-Based Non-Viral Vector, Polymer-Based Non-Viral Vector, Others)
10.2.2. By Indication (Cancer, Genetic Disease, Infectious Disease, Cardiovascular Diseases, Others)
10.2.3. By Application (Gene Therapy, Vaccinology, Cell Therapy, Others)
10.2.4. By Country
10.3. South America: Country Analysis
10.3.1. Brazil Viral & Non-Viral Vector Manufacturing Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Vector Type
10.3.1.2.2. By Indication
10.3.1.2.3. By Application
10.3.2. Argentina Viral & Non-Viral Vector Manufacturing Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Vector Type
10.3.2.2.2. By Indication
10.3.2.2.3. By Application
10.3.3. Colombia Viral & Non-Viral Vector Manufacturing Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Vector Type
10.3.3.2.2. By Indication
10.3.3.2.3. By Application
11. Middle East and Africa Viral & Non-Viral Vector Manufacturing Market Outlook
11.1. Market Size & Forecast
11.1.1. By Value
11.2. Market Share & Forecast
11.2.1. By Vector Type (Viral Vector v/s Non-Viral Vector)
11.2.1.1. By Viral Vector (Adenoviral Vector, Retroviral Vector, Lentiviral Vector, Vaccinia Viral Vector, Others)
11.2.1.2. By Non-Viral Vector (Plasmid DNA, Lipid-Based Non-Viral Vector, Polymer-Based Non-Viral Vector, Others)
11.2.2. By Indication (Cancer, Genetic Disease, Infectious Disease, Cardiovascular Diseases, Others)
11.2.3. By Application (Gene Therapy, Vaccinology, Cell Therapy, Others)
11.2.4. By Country
11.3. MEA: Country Analysis
11.3.1. South Africa Viral & Non-Viral Vector Manufacturing Market Outlook
11.3.1.1. Market Size & Forecast
11.3.1.1.1. By Value
11.3.1.2. Market Share & Forecast
11.3.1.2.1. By Vector Type
11.3.1.2.2. By Indication
11.3.1.2.3. By Application
11.3.2. Saudi Arabia Viral & Non-Viral Vector Manufacturing Market Outlook
11.3.2.1. Market Size & Forecast
11.3.2.1.1. By Value
11.3.2.2. Market Share & Forecast
11.3.2.2.1. By Vector Type
11.3.2.2.2. By Indication
11.3.2.2.3. By Application
11.3.3. UAE Viral & Non-Viral Vector Manufacturing Market Outlook
11.3.3.1. Market Size & Forecast
11.3.3.1.1. By Value
11.3.3.2. Market Share & Forecast
11.3.3.2.1. By Vector Type
11.3.3.2.2. By Indication
11.3.3.2.3. By Application
12. Market Dynamics
12.1. Drivers
12.2. Challenges
13. Market Trends & Developments
14. Competitive Landscape
14.1. Catalent, Inc.
14.2. FUJIFILM Holdings Corporation
14.3. Danaher Corporation
14.4. Genscript Biotech Corporation
14.5. Lonza Group AG
14.6. Merck KGaA Inc.
14.7. Oxford Biomedica plc
14.8. Sartorius AG
14.9. Takara Bio Inc.
14.10. Thermo Fisher Scientific Inc
15. Strategic Recommendations